FHIT and ductal breast carcinoma in situ: Three DCIS and seven invasive carcinomas with normal EGFR expression underexpressed FHIT (Table 2), which suggest that detection of FHIT expression could be of use either alone or with other markers such as EGFR, in identifying a subset of proliferative breast lesions with malignant potential.